Abstract
Current data indicate that intravenous Gp IIb/IIIa inhibitor therapy merits a prominent role in the initial management of patients with ACSs. JAMA. 2000;284:1549-1558.
Keywords
MedicineEptifibatideAbciximabTirofibanAcute coronary syndromeInternal medicineThrombusRandomized controlled trialClinical trialIntensive care medicineCardiologyPharmacologyMyocardial infarctionPercutaneous coronary intervention
MeSH Terms
AbciximabAcute DiseaseAlanineAnginaUnstableAngioplastyBalloonCoronaryAntibodiesMonoclonalAnticoagulantsBenzamidinesDrug TherapyCombinationEptifibatideHeparinLow-Molecular-WeightHumansImmunoglobulin Fab FragmentsMyocardial InfarctionOximesPeptidesPiperidinesPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexPyrrolidinesRandomized Controlled Trials as TopicStentsTirofibanTyrosine
Affiliated Institutions
Related Publications
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Although parenteral therapy with glycoprotein (GP) IIb/IIIa inhibitors has resulted in a reduced risk of death or myocardial infarction in patients with acute coronary syndromes...
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
When administered with heparin and aspirin, the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban was associated with a lower incidence of ischemic events in patients ...
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
New strategies for profound inhibition of platelet activity at the injured coronary plaque focus on blockade of the platelet surface membrane glycoprotein IIb/IIIa receptor, whi...
Stroke in Patients With Acute Coronary Syndromes
Background —The incidence of stroke in patients with acute coronary syndromes has not been clearly defined because few trials in this patient population have been large enough t...
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
In patients with unstable angina and myocardial infarction without ST-segment elevation who were treated with the glycoprotein IIb/IIIa inhibitor tirofiban, the use of an early ...
Publication Info
- Year
- 2000
- Type
- review
- Volume
- 284
- Issue
- 12
- Pages
- 1549-1549
- Citations
- 269
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
269
OpenAlex
7
Influential
207
CrossRef
Cite This
Deepak L. Bhatt
(2000).
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes.
JAMA
, 284
(12)
, 1549-1549.
https://doi.org/10.1001/jama.284.12.1549
Identifiers
- DOI
- 10.1001/jama.284.12.1549
- PMID
- 11000650